Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 192–192 | Cite as

Immunosuppressants

Cytomegalovirus reactivation: case report
Case report
  • 32 Downloads

Reference

  1. Yang Y, et al. Ruxolitinib treatment for acute gastrointestinal graft-versus-host disease caused by donor-derived CD19-Chimeric antigen receptor T-Cell infusion in a patient with B-ALL relapsed after Allo-HSCT. Regenerative Therapy 11: 139-142, Dec 2019. Available from: URL: http://doi.org/10.1016/j.reth.2019.06.006 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations